ArticleFrontiers in pharmacology2025

Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system.

Hao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.